Artykuły w czasopismach na temat „Pharmacokinetics”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Pharmacokinetics”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Iorio, Alfonso. "Using pharmacokinetics to individualize hemophilia therapy." Hematology 2017, no. 1 (2017): 595–604. http://dx.doi.org/10.1182/asheducation-2017.1.595.
Pełny tekst źródłaAshwaq, Abdulhamid Alahmadi* Maram Meshal Alsulami Khulud Khalid Alnami Mayssa Ahmed Assiri Ali Hussain Alnahwi. "PHARMACODYNAMICS AND PHARMACOKINETICS OF DIURETIC AGENTS." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 05, no. 12 (2018): 14266–70. https://doi.org/10.5281/zenodo.1974245.
Pełny tekst źródłaKamp, Jasper, Erik Olofsen, Thomas K. Henthorn, Monique van Velzen, Marieke Niesters, and Albert Dahan. "Ketamine Pharmacokinetics." Anesthesiology 133, no. 6 (2020): 1192–213. http://dx.doi.org/10.1097/aln.0000000000003577.
Pełny tekst źródłaJeong, Seung-Hyun, Ji-Hun Jang, and Yong-Bok Lee. "Pharmacokinetic Comparison between Methotrexate-Loaded Nanoparticles and Nanoemulsions as Hard- and Soft-Type Nanoformulations: A Population Pharmacokinetic Modeling Approach." Pharmaceutics 13, no. 7 (2021): 1050. http://dx.doi.org/10.3390/pharmaceutics13071050.
Pełny tekst źródłaGrzegorzewski, Jan, Janosch Brandhorst, Kathleen Green, et al. "PK-DB: pharmacokinetics database for individualized and stratified computational modeling." Nucleic Acids Research 49, no. D1 (2020): D1358—D1364. http://dx.doi.org/10.1093/nar/gkaa990.
Pełny tekst źródłaTang, Bo-Hao, Yue-E. Wu, Chen Kou, et al. "Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants." Antimicrobial Agents and Chemotherapy 63, no. 2 (2018): e02336-18. http://dx.doi.org/10.1128/aac.02336-18.
Pełny tekst źródłaLi, Qiao, Yan Yang, Ting Zhou, et al. "A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples." Molecules 23, no. 8 (2018): 2042. http://dx.doi.org/10.3390/molecules23082042.
Pełny tekst źródłaToja-Camba, Francisco José, Nerea Gesto-Antelo, Olalla Maroñas, et al. "Review of Pharmacokinetics and Pharmacogenetics in Atypical Long-Acting Injectable Antipsychotics." Pharmaceutics 13, no. 7 (2021): 935. http://dx.doi.org/10.3390/pharmaceutics13070935.
Pełny tekst źródłaJacobson, J. M., M. Davidian, P. M. Rainey, R. Hafner, R. H. Raasch, and B. J. Luft. "Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondii." Antimicrobial Agents and Chemotherapy 40, no. 6 (1996): 1360–65. http://dx.doi.org/10.1128/aac.40.6.1360.
Pełny tekst źródłaAlbitar, Orwa, Sabariah Noor Harun, Hadzliana Zainal, Baharudin Ibrahim, and Siti Maisharah Sheikh Ghadzi. "Population Pharmacokinetics of Clozapine: A Systematic Review." BioMed Research International 2020 (January 8, 2020): 1–10. http://dx.doi.org/10.1155/2020/9872936.
Pełny tekst źródłaUrbánek, Karel. "Pharmacological characteristics of subcutaneously administered monoclonal antibodies." Gastroenterologie a hepatologie 77, no. 6 (2023): 539–43. http://dx.doi.org/10.48095/ccgh2023539.
Pełny tekst źródłaWarren, Katherine E., Cynthia M. McCully, Thomas J. Walsh, and Frank M. Balis. "Effect of Fluconazole on the Pharmacokinetics of Doxorubicin in Nonhuman Primates." Antimicrobial Agents and Chemotherapy 44, no. 4 (2000): 1100–1101. http://dx.doi.org/10.1128/aac.44.4.1100-1101.2000.
Pełny tekst źródłaEgan, Talmage D., Bernou Huizinga, Samir K. Gupta, et al. "Remifentanil Pharmacokinetics in Obese versus Lean Patients." Anesthesiology 89, no. 3 (1998): 562–73. http://dx.doi.org/10.1097/00000542-199809000-00004.
Pełny tekst źródłaStepensky, David. "Pharmacokinetics of Toxin-Derived Peptide Drugs." Toxins 10, no. 11 (2018): 483. http://dx.doi.org/10.3390/toxins10110483.
Pełny tekst źródłaCook, Aaron M. "Pharmacokinetic Alterations of Antimicrobials in the Critically Ill." Journal of Pharmacy Practice 18, no. 2 (2005): 75–83. http://dx.doi.org/10.1177/0897190004273568.
Pełny tekst źródłaMuralidharan, Gopal, Richard J. Fruncillo, Marlynne Micalizzi, Donald G. Raible, and Steven M. Troy. "Effects of Age and Sex on Single-Dose Pharmacokinetics of Tigecycline in Healthy Subjects." Antimicrobial Agents and Chemotherapy 49, no. 4 (2005): 1656–59. http://dx.doi.org/10.1128/aac.49.4.1656-1659.2005.
Pełny tekst źródłaPandit, Rahul, Mirjam A. F. M. Gerrits, and Eugène J. F. M. Custers. "Assessing Knowledge of Pharmacokinetics in an Integrated Medical Curriculum." Medical Science Educator 31, no. 6 (2021): 1967–73. http://dx.doi.org/10.1007/s40670-021-01442-4.
Pełny tekst źródłaFish, Douglas N., and Edward Abraham. "Pharmacokinetics of a Clarithromycin Suspension Administered via Nasogastric Tube to Seriously Ill Patients." Antimicrobial Agents and Chemotherapy 43, no. 5 (1999): 1277–80. http://dx.doi.org/10.1128/aac.43.5.1277.
Pełny tekst źródłaHao, Guo-Xiang, Sophie Teng, Evelyne Jacqz-Aigrain, and Wei Zhao. "DO WE HAVE A CONSENSUS TO APPLY MODEL-BASED AMINOGLYCOSIDE THERAPY: A REVIEW OF POPULATION PHARMACOKINETIC MODELS." Archives of Disease in Childhood 101, no. 1 (2015): e1.51-e1. http://dx.doi.org/10.1136/archdischild-2015-310148.55.
Pełny tekst źródłaDolton, Michael J., Roger J. M. Brüggemann, David M. Burger, and Andrew J. McLachlan. "Understanding Variability in Posaconazole Exposure Using an Integrated Population Pharmacokinetic Analysis." Antimicrobial Agents and Chemotherapy 58, no. 11 (2014): 6879–85. http://dx.doi.org/10.1128/aac.03777-14.
Pełny tekst źródłaMallick, Pankajini. "Utilizing in vitro transporter data in IVIVE-PBPK: an overview." ADMET and DMPK 5, no. 4 (2017): 201–11. http://dx.doi.org/10.5599/admet.5.4.441.
Pełny tekst źródłaGarcía-Quintanilla, Laura, Andrea Luaces-Rodríguez, María Gil-Martínez, et al. "Pharmacokinetics of Intravitreal Anti-VEGF Drugs in Age-Related Macular Degeneration." Pharmaceutics 11, no. 8 (2019): 365. http://dx.doi.org/10.3390/pharmaceutics11080365.
Pełny tekst źródłaShikov, Alexander N., Elena V. Flisyuk, Ekaterina D. Obluchinskaya, and Olga N. Pozharitskaya. "Pharmacokinetics of Marine-Derived Drugs." Marine Drugs 18, no. 11 (2020): 557. http://dx.doi.org/10.3390/md18110557.
Pełny tekst źródłaAmsden, Jarrett R., Paul O. Gubbins, Scott McConnell, and Elias Anaissie. "Steady-State Pharmacokinetics of Oral Voriconazole and Its Primary Metabolite,N-Oxide Voriconazole, Pre- and Post-Autologous Peripheral Stem Cell Transplantation." Antimicrobial Agents and Chemotherapy 57, no. 7 (2013): 3420–23. http://dx.doi.org/10.1128/aac.00046-13.
Pełny tekst źródłaZhao, W., and TINN-Global Study Group. "P113 Population pharmacokinetics and dosing optimization of azlocillin in neonates." Archives of Disease in Childhood 104, no. 6 (2019): e64.3-e65. http://dx.doi.org/10.1136/archdischild-2019-esdppp.151.
Pełny tekst źródłaKalam, Muhammad Nasir, Muhammad Fawad Rasool, Asim Ur Rehman, and Naveed Ahmed. "Clinical Pharmacokinetics of Propranolol Hydrochloride: A Review." Current Drug Metabolism 21, no. 2 (2020): 89–105. http://dx.doi.org/10.2174/1389200221666200414094644.
Pełny tekst źródłaMertens, Martijn J., Erik Olofsen, Anton G. L. Burm, James G. Bovill, and Jaap Vuyk. "Mixed-effects Modeling of the Influence of Alfentanil on Propofol Pharmacokinetics." Anesthesiology 100, no. 4 (2004): 795–805. http://dx.doi.org/10.1097/00000542-200404000-00008.
Pełny tekst źródłaGinsberg, Brian, Scott Howell, Peter S. A. Glass, et al. "Pharmacokinetic Model-driven Infusion of Fentanyl in Children." Anesthesiology 85, no. 6 (1996): 1268–75. http://dx.doi.org/10.1097/00000542-199612000-00007.
Pełny tekst źródłaBailey, James M. "Technique for Quantifying the Duration of Intravenous Anesthetic Effect." Anesthesiology 83, no. 5 (1995): 1095–103. http://dx.doi.org/10.1097/00000542-199511000-00024.
Pełny tekst źródłaDebnath, Subhashis, and T. H. Harish Kumar. "An Overview on Pharmacokinetics and Pharmacokinetic Modeling." Asian Journal of Research in Pharmaceutical Science 10, no. 2 (2020): 124. http://dx.doi.org/10.5958/2231-5659.2020.00023.5.
Pełny tekst źródłaMacFadyen, Robert J., Peter A. Meredith, and Henry L. Elliott. "Enalapril Clinical Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships." Clinical Pharmacokinetics 25, no. 4 (1993): 274–82. http://dx.doi.org/10.2165/00003088-199325040-00003.
Pełny tekst źródłaSchoenwald, R. D. "Modelling of ocular pharmacokinetic processes: Corneal pharmacokinetics." Experimental Eye Research 55 (September 1992): 228. http://dx.doi.org/10.1016/0014-4835(92)91010-u.
Pełny tekst źródłaMileva, R., and A. Milanova. "Doxycycline pharmacokinetics in mammalian species of veterinary interest – an overview." BULGARIAN JOURNAL OF VETERINARY MEDICINE 25, no. 1 (2022): 1–20. http://dx.doi.org/10.15547/bjvm.2321.
Pełny tekst źródłaChild, Robert B., and Mark J. Tallon. "Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue." Nutrients 14, no. 10 (2022): 2101. http://dx.doi.org/10.3390/nu14102101.
Pełny tekst źródłaLi, Hua. "Volumetric absorptive microsampling in pharmacokinetic studies." International Journal of Pharmacokinetics 4, no. 2 (2019): IPK04. http://dx.doi.org/10.4155/ipk-2020-0001.
Pełny tekst źródłaSong, Shuliang, Qiang Wei, Ke Wang, et al. "Fluorescent Labeling of Polymannuronic Acid and Its Distribution in Mice by Tail Vein Injection." Marine Drugs 20, no. 5 (2022): 289. http://dx.doi.org/10.3390/md20050289.
Pełny tekst źródłaSong, Shuliang, Qiang Wei, Ke Wang, et al. "Fluorescent Labeling of Polymannuronic Acid and Its Distribution in Mice by Tail Vein Injection." Marine Drugs 20, no. 5 (2022): 289. http://dx.doi.org/10.3390/md20050289.
Pełny tekst źródłaSong, Shuliang, Qiang Wei, Ke Wang, et al. "Fluorescent Labeling of Polymannuronic Acid and Its Distribution in Mice by Tail Vein Injection." Marine Drugs 20, no. 5 (2022): 289. http://dx.doi.org/10.3390/md20050289.
Pełny tekst źródłaCattaneo, Dario, Sara Baldelli, Matteo Cerea, et al. "Comparison of theIn VivoPharmacokinetics andIn VitroDissolution of Raltegravir in HIV Patients Receiving the Drug by Swallowing or by Chewing." Antimicrobial Agents and Chemotherapy 56, no. 12 (2012): 6132–36. http://dx.doi.org/10.1128/aac.00942-12.
Pełny tekst źródłaAgema, Bram C., Astrid W. Oosten, Sebastiaan D. T. Sassen, et al. "Population Pharmacokinetics of Oxycodone and Metabolites in Patients with Cancer-Related Pain." Cancers 13, no. 11 (2021): 2768. http://dx.doi.org/10.3390/cancers13112768.
Pełny tekst źródłaBorsuk-De Moor, Agnieszka, and Paweł Wiczling. "The use of population modeling to optimize dosing of drugs used in anaesthesiology and intensive care." Postępy Polskiej Medycyny i Farmacji 8 (June 9, 2021): 18–23. http://dx.doi.org/10.5604/01.3001.0014.9188.
Pełny tekst źródłaHope, William W. "Population Pharmacokinetics of Voriconazole in Adults." Antimicrobial Agents and Chemotherapy 56, no. 1 (2011): 526–31. http://dx.doi.org/10.1128/aac.00702-11.
Pełny tekst źródłaWang, Xiaohu, Jin Tang, Chaozhuang Shen, Xingwen Wang, Hua Hu, and Haitang Xie. "Research Progress of Population Pharmacokinetic of Metformin." BioMed Research International 2022 (December 19, 2022): 1–10. http://dx.doi.org/10.1155/2022/4071111.
Pełny tekst źródłaVincze, István, Rita Czermann, Zsuzsanna Nagy, et al. "Assessment of Antibiotic Pharmacokinetics, Molecular Biomarkers and Clinical Status in Critically Ill Adults Diagnosed with Community-Acquired Pneumonia and Receiving Intravenous Piperacillin/Tazobactam and Hydrocortisone over the First Five Days of Intensive Care: An Observational Study (STROBE Compliant)." Journal of Clinical Medicine 11, no. 14 (2022): 4140. http://dx.doi.org/10.3390/jcm11144140.
Pełny tekst źródłaMatsuo, Yumiko, Toru Ishibashi, Alan S. Hollister, and Toshihiro Wajima. "Population Pharmacokinetics of Peramivir in Healthy Volunteers and Influenza Patients." Antimicrobial Agents and Chemotherapy 59, no. 11 (2015): 6755–62. http://dx.doi.org/10.1128/aac.00799-15.
Pełny tekst źródłaAquino, Maria, Maria Tinoco, Joana Bicker, Amílcar Falcão, Marília Rocha, and Ana Fortuna. "Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients." Antibiotics 12, no. 2 (2023): 373. http://dx.doi.org/10.3390/antibiotics12020373.
Pełny tekst źródłaSchneiderman, J. H. "Topiramate: Pharmacokinetics and Pharmacodynamics." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 25, S3 (1998): S3—S5. http://dx.doi.org/10.1017/s031716710003482x.
Pełny tekst źródłaKim, Tae, Subindra Thapa, Da Lee, et al. "Pharmacokinetics and Anti-Gastric Ulceration Activity of Oral Administration of Aceclofenac and Esomeprazole in Rats." Pharmaceutics 10, no. 3 (2018): 152. http://dx.doi.org/10.3390/pharmaceutics10030152.
Pełny tekst źródłaVashistha, Vinod Kumar, Sonika Sethi, Inderjeet Tyagi, and Dipak Kumar Das. "Chirality of antidepressive drugs: an overview of stereoselectivity." Asian Biomedicine 16, no. 2 (2022): 55–69. http://dx.doi.org/10.2478/abm-2022-0008.
Pełny tekst źródłaStraehla, Joelle P., and Katherine E. Warren. "Pharmacokinetic Principles and Their Application to Central Nervous System Tumors." Pharmaceutics 12, no. 10 (2020): 948. http://dx.doi.org/10.3390/pharmaceutics12100948.
Pełny tekst źródła